Reinventing Relevance: Five Levers for MedTech OEMs in the Era of Decentralized Diagnostics
Competing in this new landscape will require pragmatic approach, beyond mergers, acquisitions, startup acceleration, or technology additions. It calls for a rethinking of how these companies operate, how they create, deliver, and sustain value in a system that’s no longer centred on the lab. Part 1 of this article discussed a business hypothesis and a […]